Matinas BioPharma | Investor Presentation Deck | 28 slides

Matinas BioPharma · 2023-05
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

28
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
The slide uses a side-by-side comparison framework to highlight the versatility of the PS-based delivery technology.compare_peers
04
The slide uses a combination of molecular diagrams and bulleted lists to explain the mechanism and benefits of the LNC technology.present_solution
05
The slide uses a process diagram to show the self-assembly of lipoplexes into solid particles.present_solution
06
compare_peers
07
Technical mechanism slide describing biological targeting and delivery pathways.present_solution
08
The slide uses a Gantt-style visualization to represent drug development stages.plan_implementation
09
transition
Open slide detailBeat · Problem
10
Uses WHO priority pathogen list as an external validation/market driver for the company's pipeline.argue_timing
Open slide detailBeat · ProblemLoop · Cost Of Inaction
11
Uses a 'Before-After-Bridge' style logic to frame the solution.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
12
Uses a chevron-based process diagram to illustrate lifecycle management.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
13
The slide uses a process flow diagram to present five key clinical outcomes.show_traction
14
Data shows survival percentages with n/N counts below each bar group.analyze_data
15
The slide uses a timeline-based visualization to demonstrate clinical efficacy.show_traction
16
The slide uses a timeline-based process diagram to illustrate the clinical trial structure.plan_implementation
17
IFIs stands for Invasive Fungal Infections.present_solution
18
The slide presents individual patient case studies to demonstrate clinical efficacy and safety in complex, treatment-refractory cases.illustrate_case
19
The slide provides anecdotal evidence of efficacy and safety in compassionate use cases.show_traction
20
The slide uses a high-key, clean aesthetic typical of biopharma corporate decks.transition
21
The slide uses a chevron-based process flow to represent maturity stages: Proven, Under Evaluation, and Future.plan_implementation
22
Includes fluorescence microscopy images as visual proof of biological activity (GFP expression) over time.show_traction
23
Shows both in vivo (IP) and ex vivo (IM) imaging results with corresponding time-course data.show_traction
24
The slide highlights a specific partnership and its strategic benefits.present_solution
25
The slide uses a grid-based timeline format to track specific technical achievements and future partnership goals.plan_implementation
27
other
Open slide detailBeat · Team
28
The slide combines financial runway, a timeline of upcoming catalysts, and a summary of the investment thesis (floor vs upside).summarize